Literature DB >> 11374689

Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea.

W Y Chey1, H O Jin, M H Lee, S W Sun, K Y Lee.   

Abstract

OBJECTIVES: Although colon dysmotility is recognized as a pathophysiological factor in irritable bowel syndrome (IBS), it has not been characterized. We have investigated motility patterns in IBS patients with abdominal pain and frequent defecation or diarrhea and in healthy volunteers.
METHODS: A recording catheter that had six polyvinyl tubes with infusion ports was placed in the transverse, descending, and sigmoid colon under fluoroscopy. After 2-h basal recordings, motility responses to cholecystokinin octapeptide (CCK-8) and a meal were studied for 3 h. The motility index (MI) and number of high amplitude propagating contractions (HAPCs) in 10 IBS patients were compared with those of 10 controls. HAPCs were correlated with abdominal pain, and colon transit time using radio-opaque markers was determined. Using human colon muscle strips, the effect of CCK-8 on muscle contractions was also studied.
RESULTS: The MI and mean number and peak amplitude of HAPCs in IBS patients were significantly greater than in controls. These abnormalities paralleled markedly shortened colonic transit time. Abdominal pain coincided with >90% of HAPCs. Dose-dependent muscle contraction by CCK-8 was profoundly suppressed both by loxiglumide and atropine.
CONCLUSIONS: The dysmotility in this subset of IBS patients was characterized by significantly increased occurrences of powerful HAPCs that paralleled rapid colon transit and were accompanied by abdominal pain. Thus, it is suggested that this powerful contraction is one of the causes of abdominal pain. The action of CCK-8 seems to be mediated via the colon enteric nervous system.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11374689     DOI: 10.1111/j.1572-0241.2001.03804.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  87 in total

1.  Of actors, bolting horses, and drops in oceans!

Authors:  F Cremonini; M Camilleri
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

Review 2.  Treating irritable bowel syndrome: overview, perspective and future therapies.

Authors:  Michael Camilleri
Journal:  Br J Pharmacol       Date:  2004-03-22       Impact factor: 8.739

3.  Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.

Authors:  B S Wong; M Camilleri; D Eckert; P Carlson; M Ryks; D Burton; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2012-01-30       Impact factor: 3.598

4.  Altering the gastrointestinal flora in patients with functional bowel disorders: a way ahead?

Authors:  Magnus Simrén
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 5.  A Systematic Review of the Effects of Polyols on Gastrointestinal Health and Irritable Bowel Syndrome.

Authors:  Adrienne Lenhart; William D Chey
Journal:  Adv Nutr       Date:  2017-07-14       Impact factor: 8.701

Review 6.  Factors influencing functional abdominal pain in children.

Authors:  Ashis V Barad; Miguel Saps
Journal:  Curr Gastroenterol Rep       Date:  2008-06

7.  Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway.

Authors:  M Fornai; R Colucci; L Antonioli; F Crema; P Buccianti; M Chiarugi; F Baschiera; N Ghisu; M Tuccori; C Blandizzi; M Del Tacca
Journal:  Br J Pharmacol       Date:  2007-06-18       Impact factor: 8.739

8.  Age-related symptom and life quality changes in women with irritable bowel syndrome.

Authors:  Yu-Rong Tang; Wei-Wei Yang; Mei-Lan Liang; Xin-Yu Xu; Mei-Feng Wang; Lin Lin
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

9.  Mechanisms of cholecystokinin-induced calcium mobilization in gastric antral interstitial cells of Cajal.

Authors:  Yao-Yao Gong; Xin-Min Si; Lin Lin; Jia Lu
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

10.  Food Intolerance: Dietary Treatments in Functional Bowel Disorders.

Authors:  Maria O'Sullivan; Colm O'Morain
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.